Skip to main content

schizophrenia Archives

Grant spurs schizophrenia research

Feb. 12, 2015—Vanderbilt University is partnering with the William K. Warren Foundation of Tulsa, Oklahoma, on research aimed at improving the treatment of schizophrenia and other forms of serious mental illness.

Read more


Hazy definition may hamper catatonia care

Feb. 12, 2015—Catatonia, a syndrome characterized by muscular rigidity and a trance-like mental stupor, can at times manifest with great excitement and confusion. And while it is often associated with schizophrenia, it can present in patients with either medical or psychiatric conditions. For this reason, the condition has often confused clinicians.

Read more


New view of dopamine heteromers

Jan. 23, 2015—Although heteromeric dopamine receptors composed of both D1 and D2 subunits have been proposed to play a role in depression and schizophrenia, recent studies suggest these heteromers do not exist.

Read more


Family’s gift bolsters schizophrenia research, treatment

Dec. 18, 2014—A “transformational” $6.4 million gift from Dallas couple Donald Test Jr., and his wife, Charlotte, who have a very personal connection to the devastating disease of schizophrenia, is supporting Vanderbilt Department of Psychiatry research and treatment into schizophrenia and related disorders.

Read more


VU study reveals shared pathways in psychiatric disorders

Sep. 18, 2014—Schizophrenia and bipolar disorder share common genetic underpinnings. Vanderbilt researchers combined high-resolution gene expression studies with gene association data to reveal signaling pathways linked to schizophrenia and bipolar disorder.

Read more


Schizophrenia ‘switches’ discovered

Sep. 12, 2014—Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.

Read more


Brain mapping confirms patients with schizophrenia have impaired ability to imitate

Mar. 14, 2014—A brain-mapping study of patients with schizophrenia has found that areas associated with the ability to imitate are impaired, providing new support for the theory that deficits in this basic cognitive skill may underlie the profound difficulty with social interactions that characterize the disorder.

Read more


‘Missing link’ may spur new brain disorder drugs

Mar. 13, 2014—Researchers at the Scripps Research Institute in San Diego and Vanderbilt University have discovered a “missing link” in the structure of a transmembrane receptor that could lead to new treatments for autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease.

Read more


Vanderbilt study reveals senses of sight and sound separated in children with autism

Jan. 14, 2014—Children with autism spectrum disorders have trouble integrating simultaneous information from their eyes and their ears--as if they experience the world like a badly-dubbed movie.

Read more


Transporter linked to autism risk

Sep. 19, 2013—Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD).

Read more


Nobel in Chemistry reveals VU ties that bind

Oct. 18, 2012—Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.

Read more


Insights for neuroscience drug discovery

Jul. 17, 2012—When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.

Read more


Page 2 of 41234